A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy
CompletedOBSERVATIONAL
Enrollment
117
Participants
Timeline
Start Date
April 11, 2016
Primary Completion Date
July 3, 2017
Study Completion Date
July 3, 2017
Conditions
EpilepsyPartial-onset Seizures
Interventions
DRUG
Perampanel
Perampanel tablets.
All Listed Sponsors
lead
Eisai Co., Ltd.
INDUSTRY
NCT04230044 - A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy | Biotech Hunter | Biotech Hunter